A
Anna Moshnikova
Researcher at University of Rhode Island
Publications - 42
Citations - 1663
Anna Moshnikova is an academic researcher from University of Rhode Island. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 19, co-authored 35 publications receiving 1328 citations. Previous affiliations of Anna Moshnikova include Russian Academy of Sciences & University of Virginia.
Papers
More filters
Journal ArticleDOI
Family of pH (low) insertion peptides for tumor targeting
Dhammika Weerakkody,Anna Moshnikova,Mak S. Thakur,Valentina Moshnikova,Jennifer Daniels,Donald M. Engelman,Oleg A. Andreev,Yana K. Reshetnyak +7 more
TL;DR: A library of 16 rationally designed pHLIP variants is reported on, showing how the tuning of the biophysical properties of peptide–lipid bilayer interactions alters tumor targeting, distribution in organs, and blood clearance.
Journal ArticleDOI
Probe for the measurement of cell surface pH in vivo and ex vivo
TL;DR: A probe that uses a pH low insertion peptide to locate a pH-sensing dye at acidic cell surfaces is developed and it is found that the probe can measure surface pH, which is correlated with tumor aggressiveness and is sensitive to cell glycolytic activity.
Journal ArticleDOI
pHLIP peptide targets nanogold particles to tumors
Lan Yao,Jennifer Daniels,Anna Moshnikova,Sergey G. Kuznetsov,Aftab Ahmed,Donald M. Engelman,Yana K. Reshetnyak,Oleg A. Andreev +7 more
TL;DR: In this article, a method for the preferential targeting of gold nanoparticles to a tumor in a mouse model is described, which is based on the use of the pH Low Insertion Peptide (pHLIP), which targets various imaging agents to acidic tumors.
Journal Article
pHLIP Peptide Targets Nanogold Particles to Tumors
Jennifer Daniels,Lan Yao,Anna Moshnikova,Sergey G. Kuznetsov,Aftab Ahmed,Donald M. Engelman,Yana K. Reshetnyak,Oleg A. Andreev +7 more
TL;DR: The pHLIP technology can substantially improve the delivery of gold nanoparticles to tumors by providing specificity of targeting, enhancing local concentration in tumors, and distributing nanoparticles throughout the entire tumor mass where they remain for an extended period (several days), which is beneficial for radiation oncology and imaging.
Journal ArticleDOI
Novel type of Ras effector interaction established between tumour suppressor NORE1A and Ras switch II
Benjamin Stieglitz,Christine Bee,Daniel Schwarz,Özkan Yildiz,Anna Moshnikova,Andrei Khokhlatchev,Christian Herrmann +6 more
TL;DR: The crystal structure of Ras in complex with the Ras binding domain (RBD) of NORE1A/RAPL is described and it is demonstrated that the enlarged interface provides a rationale for an exceptionally long lifetime of the complex.